DELIVERY ORDER

PRIME MARKET PHARMACEUTICALS - U&O

Awarded to MCKESSON CORPORATION

PIID 75H71222F80147US · USAspendingBiotechnology & Pharmaceuticals
$650K
Data last updated Oct 22, 2026 · Source: USAspending
Transaction obligation$650,000sum disclosed on award record
Current contract valueNot reportednot interchangeable with obligation
Potential contract valueNot reportedincluding options if reported
Award dateJul 20, 2022
Company legal name
MCKESSON CORPORATION
UEI / CAGE
S1RUKWWRYFL6 / Not reported
Parent award
Not reported
Awarding agency
Department of Health and Human Services
Subagency
Indian Health Service
Industry
Biotechnology & Pharmaceuticals
NAICS
325412
PSC
6505
Performance period
Not reported — Not reported
Recipient address
6555 STATE HIGHWAY 161, IRVING, DALLAS, TX, 75039
Place of performance
FORT DUCHESNE, UINTAH, UT, 84026
Source last modified
Nov 3, 2026

Description

PRIME MARKET PHARMACEUTICALS - U&O

View federal source ↗

Derived from official transactions

Contract lifecycle

  1. Award announced

    PRIME MARKET PHARMACEUTICALS - U&O

    US · usaspendingSource ↗
  2. Value increased

    PRIME MARKET PHARMACEUTICALS - U&O

    US · usaspending$650KSource ↗

Point-in-time model

Contract change outlook

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Uncollapsed source history

Transactions and modifications

Action dateModificationAction typeExact obligationCurrent totalPotential totalDescriptionSource
Jul 27, 20220Not reported$650,000.00Not reportedNot reportedPRIME MARKET PHARMACEUTICALS - U&OUSAspending ↗